AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-79
Results: 1-25/79
CARBOPLATIN DOSAGE FORMULAS CAN GENERATE INACCURATE PREDICTIONS OF CARBOPLATIN EXPOSURE IN CARBOPLATIN PACLITAXEL COMBINATION REGIMENS/
Authors: PANDAY VRN VANWARMERDAM LJC HUIZING MT HUININK WWT VERMORKEN JB GIACCONE G VEENHOF CHN SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., CARBOPLATIN DOSAGE FORMULAS CAN GENERATE INACCURATE PREDICTIONS OF CARBOPLATIN EXPOSURE IN CARBOPLATIN PACLITAXEL COMBINATION REGIMENS/, Clinical drug investigation, 15(4), 1998, pp. 327-335
SENSITIVE DETERMINATION OF THE CARBOXYLATE AND LACTONE FORMS OF THE NOVEL ANTITUMOR DRUG IRINOTECAN AND ITS ACTIVE METABOLITE IN PLASMA BY HPLC
Authors: HERBEN VMM MAZEE D VANGORTELVANZOMEREN DM ZEEDIJK S ROSING H SCHELLENS JHM HUININK WWT BEIJNEN JH
Citation: Vmm. Herben et al., SENSITIVE DETERMINATION OF THE CARBOXYLATE AND LACTONE FORMS OF THE NOVEL ANTITUMOR DRUG IRINOTECAN AND ITS ACTIVE METABOLITE IN PLASMA BY HPLC, Journal of liquid chromatography & related technologies, 21(10), 1998, pp. 1541-1558
PHARMACOLOGICAL STUDY OF 3-HOUR 135 MG M(-2) PACLITAXEL IN PLATINUM PRETREATED PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: PANDAY VRN HUIZING MT VANWARMERDAM LJC DUBBELMAN RC MANDJES I SCHELLENS JHM HUININK WWT BEIJNEN JH
Citation: Vrn. Panday et al., PHARMACOLOGICAL STUDY OF 3-HOUR 135 MG M(-2) PACLITAXEL IN PLATINUM PRETREATED PATIENTS WITH ADVANCED OVARIAN-CANCER, Pharmacological research, 38(3), 1998, pp. 231-236
INTRAPERITONEAL CISPLATIN WITH REGIONAL HYPERTHERMIA IN ADVANCED OVARIAN-CANCER - PHARMACOKINETICS AND CISPLATIN-DNA ADDUCT FORMATION IN PATIENTS AND OVARIAN-CANCER CELL-LINES
Authors: VANDEVAART PJM VANDERVANGE N ZOETMULDER FAN VANGOETHEM AR VANTELLINGEN O HUININK WWT BEIJNEN JH BARTELINK H BEGG AC
Citation: Pjm. Vandevaart et al., INTRAPERITONEAL CISPLATIN WITH REGIONAL HYPERTHERMIA IN ADVANCED OVARIAN-CANCER - PHARMACOKINETICS AND CISPLATIN-DNA ADDUCT FORMATION IN PATIENTS AND OVARIAN-CANCER CELL-LINES, European journal of cancer, 34(1), 1998, pp. 148-154
PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY DOXORUBICIN AND 1 HR INFUSIONAL PACLITAXEL IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: PANDAY VRN HUININK WWT ROSING H KOOPMAN FJ HILLEBRAND MJX DUBBELMAN RC VANTELLINGEN O SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY DOXORUBICIN AND 1 HR INFUSIONAL PACLITAXEL IN PATIENTS WITH ADVANCED BREAST-CANCER, Anti-cancer drugs, 9(8), 1998, pp. 665-673
CONTINUOUS-INFUSION OF LOW-DOSE TOPOTECAN - PHARMACOKINETICS AND PHARMACODYNAMICS DURING A PHASE-II STUDY IN PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: HERBEN VMM HUININK WWT SCHOT ME HUDSON I BEIJNEN JH
Citation: Vmm. Herben et al., CONTINUOUS-INFUSION OF LOW-DOSE TOPOTECAN - PHARMACOKINETICS AND PHARMACODYNAMICS DURING A PHASE-II STUDY IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Anti-cancer drugs, 9(5), 1998, pp. 411-418
CLINICAL PHARMACOKINETICS OF CAMPTOTHECIN TOPOISOMERASE-I INHIBITORS
Authors: HERBEN VMM HUININK WWT SCHELLENS JHM BEIJNEN JH
Citation: Vmm. Herben et al., CLINICAL PHARMACOKINETICS OF CAMPTOTHECIN TOPOISOMERASE-I INHIBITORS, Pharmacy world & science, 20(4), 1998, pp. 161-172
A NEW ORAL DOSAGE FORM OF TOPOTECAN - BIOAVAILABILITY AND EFFECT OF FOOD COADMINISTRATION
Authors: HERBEN VMM SCHELLENS JHM HUININK WWT ROSING H VANZOMEREN DM BEUSENBERG FB ROSS G BEIJNEN JH
Citation: Vmm. Herben et al., A NEW ORAL DOSAGE FORM OF TOPOTECAN - BIOAVAILABILITY AND EFFECT OF FOOD COADMINISTRATION, Annals of oncology, 9, 1998, pp. 227-227
PHASE-I AND PHARMACOLOGICAL STUDY WITH THE NOVEL TOPOISOMERASE I II INHIBITOR INTOPLICINE ADMINISTERED AS A 24-HOUR INFUSION/
Authors: VANGIJN R HUININK WWT RODENHUIS S VERMORKEN JB VANTELLINGEN O ROSING H VANWARMERDAM LJC ALAKL MK BEIJNEN JH
Citation: R. Vangijn et al., PHASE-I AND PHARMACOLOGICAL STUDY WITH THE NOVEL TOPOISOMERASE I II INHIBITOR INTOPLICINE ADMINISTERED AS A 24-HOUR INFUSION/, Annals of oncology, 9, 1998, pp. 251-251
PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY BOLUS DOXORUBICIN AND 1-HOUR PACLITAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: PANDAY VRN HUININK WWT ROSING H VANTELLINGEN O SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY BOLUS DOXORUBICIN AND 1-HOUR PACLITAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 368-368
PHASE-I AND PHARMACOLOGICAL STUDY OF SPI-77, A NEW LIPOSOMAL ENCAPSULATED FORMULATION OF CISPLATIN (CDDP)
Authors: TERWOGT JMM BEIJNEN JH HUININK WWT MALIEPAARD M TIBBEN M WELBANK H GROENEWEGEN G SCHELLENS JHM
Citation: Jmm. Terwogt et al., PHASE-I AND PHARMACOLOGICAL STUDY OF SPI-77, A NEW LIPOSOMAL ENCAPSULATED FORMULATION OF CISPLATIN (CDDP), Annals of oncology, 9, 1998, pp. 464-464
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE INVESTIGATIONAL ANTICANCER DRUG 9-AMINOCAMPTOTHECIN, AS THE LACTONE FORM AND AS THETOTAL OF THE LACTONE AND THE HYDROXYCARBOXYLATE FORMS, IN MICRO-VOLUMES OF HUMAN PLASMA
Authors: VANGIJN R HERBEN VMM HILLEBRAND MJX HUININK WWT BULT A BEIJNEN JH
Citation: R. Vangijn et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE INVESTIGATIONAL ANTICANCER DRUG 9-AMINOCAMPTOTHECIN, AS THE LACTONE FORM AND AS THETOTAL OF THE LACTONE AND THE HYDROXYCARBOXYLATE FORMS, IN MICRO-VOLUMES OF HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1257-1265
CARDIAC DYSFUNCTION IN CANCER-PATIENTS RECEIVING PACLITAXEL
Authors: OLMOS RAV HUININK WWT HOEFNAGEL CA
Citation: Rav. Olmos et al., CARDIAC DYSFUNCTION IN CANCER-PATIENTS RECEIVING PACLITAXEL, European journal of nuclear medicine, 25(4), 1998, pp. 446-447
COADMINISTRATION OF CYCLOSPORINE ENABLES ORAL-THERAPY WITH PACLITAXEL
Authors: TERWOGT JMM BEIJNEN JH HUININK WWT ROSING H SCHELLENS JHM
Citation: Jmm. Terwogt et al., COADMINISTRATION OF CYCLOSPORINE ENABLES ORAL-THERAPY WITH PACLITAXEL, Lancet, 352(9124), 1998, pp. 285-285
4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP
Authors: DEWIT R STOTER G SLEIJFER D NEIJT JP HUININK WWT DEPRIJCK L COLLETTE L SYLVESTER R
Citation: R. Dewit et al., 4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP, British Journal of Cancer, 78(6), 1998, pp. 828-832
CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS
Authors: AABO K ADAMS M ADNITT P ALBERTS DS ATHANAZZIOU A BARLEY V BELL DR BIANCHI U BOLIS G BRADY MF BRODOVSKY HS BRUCKNER H BUYSE M CANETTA R CHYLAK V COHEN CJ COLOMBO N CONTE PF CROWTHER D EDMONSON JH GENNATAS C GILBEY E GORE M GUTHRIE D KAYE SB LAING AH LANDONI F LEONARD RC LEWIS C LIU PY MANGIONI C MARSONI S MEERPOHL H OMURA GA PARMAR MKB PATER J PECORELLI S PRESTI M SAUERBREI W SKARLOS DV SMALLEY RV SOLOMON HJ STEWART LA STURGEON JFG TATTERSALL MHN WHARTON JT HUININK WWT TOMIROTTI M TORRI W TROPE C TURBOW MM VERMORKEN JB WEBB MJ WILBUR DW WILLIAMS CJ WILTSHAW E YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE
Authors: DEWIT R COLLETTE L SYLVESTER R DEMULDER PHM SLEIJFER DT HUININK WWT KAYE SB VANOOSTEROM AT BOVEN E STOTER G
Citation: R. Dewit et al., SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE, British Journal of Cancer, 78(10), 1998, pp. 1350-1355
BIOANALYSIS OF DOCETAXEL AND HYDROXYLATED METABOLITES IN HUMAN PLASMABY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND AUTOMATED SOLID-PHASE EXTRACTION
Authors: ROSING H LUSTIG V KOOPMAN FP HUININK WWT BEIJNEN JH
Citation: H. Rosing et al., BIOANALYSIS OF DOCETAXEL AND HYDROXYLATED METABOLITES IN HUMAN PLASMABY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND AUTOMATED SOLID-PHASE EXTRACTION, Journal of chromatography B. Biomedical sciences and applications, 696(1), 1997, pp. 89-98
HYPERSENSITIVITY REACTIONS TO THE TAXANES PACLITAXEL AND DOCETAXEL
Authors: PANDAY VRN HUIZING MT HUININK WWT VERMORKEN JB BEIJNEN JH
Citation: Vrn. Panday et al., HYPERSENSITIVITY REACTIONS TO THE TAXANES PACLITAXEL AND DOCETAXEL, Clinical drug investigation, 14(5), 1997, pp. 418-427
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE
Authors: ROSING H VANGIJN R HUININK WWT BEIJNEN JH
Citation: H. Rosing et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE, Journal of liquid chromatography & related technologies, 20(4), 1997, pp. 583-601
A PHASE-II STUDY WITH GI147211 IN OVARIAN-CANCER
Authors: WANDERS J VANOOSTEROM AT GORE M CALVERT AH HUININK WWT HANSEN HH WISSEL P HANAUSKE AR
Citation: J. Wanders et al., A PHASE-II STUDY WITH GI147211 IN OVARIAN-CANCER, European journal of cancer, 33, 1997, pp. 528-528
PHASE-II STUDIES WITH GI147211 (GI) IN BREAST (B), COLORECTAL (C) ANDNON-SMALL-CELL LUNG-CANCER (N)
Authors: WANDERS J HUININK WWT PAVLIDIS N KAYE SB SESSA C LEHNERT M PICCART M PARIDAENS R WISSEL P HANAUSKE AR
Citation: J. Wanders et al., PHASE-II STUDIES WITH GI147211 (GI) IN BREAST (B), COLORECTAL (C) ANDNON-SMALL-CELL LUNG-CANCER (N), European journal of cancer, 33, 1997, pp. 705-705
PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT11) WITH A PROLONGED (14D) INFUSION SCHEDULE
Authors: HERBEN V SCHELLENS J SWART M GRUIA G BEYNEN J HUININK WWT
Citation: V. Herben et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF IRINOTECAN (CPT11) WITH A PROLONGED (14D) INFUSION SCHEDULE, European journal of cancer, 33, 1997, pp. 1143-1143
DOCETAXEL ALTERNATING WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITY STUDY IN BREAST-CANCER PATIENTS
Authors: HUININK WWT LUSTIG V DUBBELMAN R HIEMSTRA A RODENHUIS S
Citation: Wwt. Huinink et al., DOCETAXEL ALTERNATING WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITY STUDY IN BREAST-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 23-25
PHASE-II STUDY OF THE COMBINATION CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER
Authors: HUININK WWT VANWARMERDAM LJC HELMERHORST TJ SCHAEFERS MCW BEIJNEN JH RODENHUIS S
Citation: Wwt. Huinink et al., PHASE-II STUDY OF THE COMBINATION CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH OVARIAN-CANCER, Annals of oncology, 8(4), 1997, pp. 351-354
Risultati: 1-25 | 26-50 | 51-75 | 76-79